Google Play
MedQuest
MedQuest – Preparatory course for the INEP Revalidation Exam.
13 Nov 2025launched 11 months ago
–No ratings yetRead reviews
100+installs on Google Play
Seen in 1 countryTurkey
1.3.3latest version · 11 months ago
Where these dates come from
- Launch date Store figure
- 13 Nov 2025 is Google Play’s date. Google Play dates an app per country, and this one has not been checked against other countries yet.
- First seen by IndieTower Our record
- 10 Oct 2026. The day we first met this app, which can be long after it launched.
- Last read from the store Our record
- 10 Oct 2026. Ratings, version and store page on this page are as of that read.
Estimated downloads
IndieTower estimateSee how many downloads this app getsEstimates for every app are part of the Indie plan.
Unlock with Indie · $12 a monthScreenshots
About
MedQuest – INEP Revalidation Preparation Course Accelerate your approval with the most direct and complete course for the Revalida exam. Quick, dynamic classes focused on what actually appears on the test. Study wherever and whenever you want, with questions to answer at the end of each class, mock exams, and personalized schedules. All in the palm of your hand.Read more
MedQuest – INEP Revalidation Preparation Course
Accelerate your approval with the most direct and complete course for the Revalida exam.
Quick, dynamic classes focused on what actually appears on the test.
Study wherever and whenever you want, with questions to answer at the end of each class, mock exams, and personalized schedules.
All in the palm of your hand.
Store page changes
Title, subtitle, icon, screenshots and priceNo changes recorded yet. Each time we check this app we compare its store page with the last one and log what changed. Create a free account and save this app to have its store page checked every day.
Versions
- Version 1.3.3First seen · 13 Nov 2025
Countries
Seen in 1 country Soft launch
Countries where IndieTower has seen this app in charts, search or store pages.
Turkey
Chart positions
Not seen in the charts we track yet.
